Innovation Summit – Obesity, Diabetes & the Metabolic Crisis

November 2, 2010

This week I attended the Cleveland Clinic Innovation Summit and contributed to the live tweeting of the event. There was substantial discussion of devices in the pipeline and drugs for diabetes but a less optimistic outlook on drugs for obesity with some being shut down by the FDA. The most scientific yet controversial presenter was JefferyFriedman, who referred to his 2009 Newsweek article on “The Real Cause of Obesity” as a summary of his position that most of obesity is genetically determined.  Many referred to the recent prediction posted by the CDC that the current incidence of diabetes being around 10% of the population with the potential of growing to 20 – 30% by 2050.

At the end of day two, the annual announcement of Top 10 Innovations. The final day will include health IT interventions for obesity and diabetes.

Share this:
  • Facebook
  • Twitter
  • Delicious
  • Digg
  • Tumblr
  • StumbleUpon
  • Pinterest
  • Add to favorites
  • Email
  • RSS

Leave a Reply